top of page

Nicotinamide Riboside (NR) IV Therapy in Las Vegas
 

NR is a nicotinamide adenine dinucleotide (NAD+) precursor involved in cellular energy metabolism. Protocol selection and dosing are individualized based on clinical assessment, prior response, and patient-specific factors; outcomes and tolerability vary.

NR Infusion125mg - $240
NR Infusion 250mg - $480
NR Infusion 500mg - $830
NR Infusion 750mg - $1230
NR Infusion 1000mg  $1660

NR-IV.jpg

NR (Nicotinamide Riboside) IV vs NAD⁺ IV
Understanding the Difference, Benefits, and Why We Offer Both. 
NAD⁺ therapy has become widely recognized for its role in cellular energy, mitochondrial function, and healthy aging. However, not all NAD-related IV therapies work the same way. At IV Vitamin Therapy Clinic, we offer both Nicotinamide Riboside (NR) IV and NAD⁺ IV to support NAD⁺ levels through complementary mechanisms — allowing for a more personalized, medically guided approach.

What's Inside

  • Nad+ 500ml Electrolytes

What Is Nicotinamide Riboside (NR)?
NR IV therapy delivers nicotinamide riboside directly into the bloodstream, with 100% percent absorbtion. 
Nicotinamide riboside (NR) has recently become one of the most studied nicotinamide adenine dinucleotide (NAD+) precursors, due to its numerous potential health benefits mediated via elevated NAD+ content in the body. NAD+ is an essential coenzyme that plays important roles in various metabolic pathways and increasing its overall content has been confirmed as a valuable strategy for treating a wide variety of pathophysiological conditions.

Accumulating evidence on NRs’ health benefits has validated its efficiency across numerous animal and human studies for the treatment of a number of cardiovascular, neurodegenerative, and metabolic disorders. As the prevalence and morbidity of these conditions increases in modern society, the great necessity has arisen for a rapid translation of NR to therapeutic use and further establishment of its availability as a nutritional supplement. Here, we summarize currently available data on NR effects on metabolism, and several neurodegenerative and cardiovascular disorders, through to its application as a treatment for specific pathophysiological conditions. In addition, we have reviewed newly published research on the application of NR as a potential therapy against infections with several pathogens, including SARS-CoV-2. Additionally, to support rapid NR translation to therapeutics, the challenges related to its bioavailability and safety are addressed, together with the advantages of NR to other NAD+ precursors.


Once administered:

  • NR enters cells efficiently

  • It is converted into NAD⁺ intracellularly

  • NAD⁺ is then available to support normal cellular metabolic functions

This pathway allows the body to regulate NAD⁺ production internally, rather than delivering NAD⁺ directly.


Why NR Is Offered in IV Form
 
While NR is commonly taken orally, intravenous administration offers several practical advantages in a clinical setting:

  • Direct delivery without digestive breakdown

  • Predictable dosing under medical supervision

  • Shorter infusion times compared to NAD⁺ IV

  • Generally well tolerated by patients

NR IV therapy is often selected by individuals seeking cellular and mitochondrial support without the prolonged infusion times associated with traditional NAD⁺ IV therapy.

  • Cellular repair and recovery

  • Improved mitochondrial ATP production

  • Reduced oxidative stress and inflammation

  • Enhanced vascular responsiveness and microcirculation

  • Neurologic, muscular, and metabolic tissue health

By optimizing the cellular environment, NAD⁺ IV therapy helps the body’s natural healing and recovery processes function at a higher level—particularly in aging tissue, post-inflammatory states, neurologic stress, and high-performance demands.

Benefits of NR IV Therapy

  • Supports intracellular NAD⁺ synthesis via established salvage pathways

  • Facilitates mitochondrial oxidative metabolism and ATP generation

  • Provides a precursor-based approach to NAD⁺ repletion rather than direct coenzyme delivery

  • Allows for shorter infusion duration compared with NAD⁺ IV therapy

  • Demonstrates favorable tolerability in clinical use

  • Enables controlled dosing and administration under licensed medical supervision

  • Bypasses gastrointestinal absorption variability associated with oral NR supplementation

  • Supports enzymatic processes involved in cellular stress response and maintenance


Treatment Duration

  • NR IV therapy is typically administered more quickly than traditional NAD⁺ infusions.

  • Faster infusion rates are generally associated with fewer infusion-related discomforts.

  • Lower incidence of chest pressure, flushing, or nausea compared to slower NAD⁺ infusions.

  • Shorter infusion durations reduce interruptions and variability during administration.

Niagen.jpg
!
bottom of page